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Abstract

Matrix metalloproteases (MMPs) are proteolytic enzymes secreted by cardiac
fibroblasts. Altered expression of MMPs plays an important role in congestive heart
failure and other cardiovascular diseases 1•2 • Emerging evidence has led us to consider the
role of phosphatidylinositol 4-kinase (Ptdlns 4-kinase) in regulating MMP secretion in
cardiac fibroblast cells 3- 7 . Ptdlns 4-kinase is a lipid kinase involved in various cellular
processes including protein secretion. This project was designed to test the hypothesis
that Ptdlns 4-kinase controls MMP secretion. Techniques such as cardiac cell culture,
transfection, and in-gel zymography were used for this experiment. Results demonstrated
that Ptdlns 4-kinase regulates MMP secretion. This research will provide insights in
revealing molecular details of congestive heart failure and will contribute to the
development of strategies against cardiovascular diseases.

Abbreviations used:
APMA - 4-aminophenyl mercuric acetate
CVD - cardiovascular disease
ECM - extracellular matrix
GFP - green fluorescent protein
HBSS - Hanks buffered saline solution
MMP - matrix metalloprotease
Ptdlns - phosphatidylinositol
Ptdlns 4-kinase - phosphatidylinositol 4-kinase
Ptdlns-4P - phosphatidylinositol 4-phosphate
Ptdlns (4,5)P 2 - phosphatidylinositol-4,5-bisphosphate
SOS - sodium dodecyl sulfate
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Introduction

Since 1900, cardiovascular disease (CVD) has been the leading cause of death in
the United States except in 1918. In a 2006 update, the American Heart Association
estimated that more than 71,300,000 Americans have one or more forms of CVD. In
particular, five million Americans are affected by one type of CVD called congestive
heart failure 8• Therefore, understanding the development of cardiovascular diseases at
the molecular and cellular level was the motive for this study. By understanding the
events that lead to cardiovascular diseases, we can develop specific interventions and
treatments that could slow or reverse this process.
An area of growing research is the association of heart extracellular matrix (ECM)

with congestive heart failure. The extracellular matrix consists of complex network of
proteins and polysaccharides that forms a dynamic meshwork and occupies a significant
portion of the extracellular space in mammalian tissues. This matrix is involved in many
cellular functions including structural support to tissues and intercellular communication.
The normal heart ECM is predominately composed of collagen polymers which serve as
major contributors to structural integrity of tissues 9 .
The cardiac fibroblast cells are mainly responsible for the synthesis of ECM
collagen. In addition, fibroblasts regulate ECM collagen through the secretion of
proteolytic enzymes called matrix metalloproteases (MMPs). These enzymes are
constitutively expressed and play a critical role in controlling the composition and form
of the ECM. However, improper MMP levels have been associated with several
cardiovascular diseases. Previous studies have shown that serum MMP levels are
significantly elevated in patients with congestive heart failure 1• Further, increased MMP
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activity is also associated with cardiomyopathy and contractile dysfunction 2 . Hence, the
goal of this research is to determine the underlying mechanisms that regulate MMP
secretion.
In this research project, the control of MMP secretion by phosphatidylinositol 4kinase (Ptdlns 4-kinase) was examined. Ptdlns 4-kinase is a lipid kinase that regulates
numerous cellular processes including vesicular transport, signal transduction, and
cytoskeleton remodeling

10
•

Its activity is primarily membrane associated and localized to

the nuclear envelope, endoplasmic reticulum, Golgi, lysosome, and plasma membrane 1°12.

Ptdins 4-kinases function by converting phosphatidylinositol (Ptdlns) into

phosphatidylinositol 4-phosphate (Ptdlns-4P). Ptdlns-4P can directly interact with target
proteins or be converted to phosphatidylinositol-4,5-bisphosphate

(Ptdins( 4,5)P 2).

Ptdlns( 4,5)P 2 is commonly known as a signaling molecule and a substrate for
phospholipase C to produce inositol 1,4,5-trisphosphate and diacylglycerol.
Because of its tractable nature, the yeast Saccharomyces cerevisiae has proven to
be a useful organism to study secretory protein transport. In addition, the mechanism of
protein secretion in yeast is generally conserved in mammalian cells 13• In 1999, Hama
and colleagues demonstrated that yeast Ptdlns 4-kinase is involved in Golgi-to-plasma
membrane vesicular transport 3-5 . In addition, it has been shown that Ptdins 4-kinases
have an important role in protein secretion in higher eukaryotes 6 .
A previous work by Edgar Lee demonstrated that Wortmannin, a known inhibitor
of Ptdlns 4-kinase, decreased MMP secretion in ordinary fibroblast cells 7 • This
preliminary study suggested that Ptdlns 4-kinase may play a significant role in cardiac
fibroblast cells. Therefore, we hypothesized that Ptdlns 4-kinase regulates MMP
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secretion in cardiac fibroblast cells. To observe the functional role of Ptdlns 4-kinase,
overexpressed wild type Ptdlns 4-kinase (overexpressed wt) and overexpressed pointmutated Ptdlns 4-kinase (overexpressed pm) were constructed. These recombinant genes
created a dominant negative phenotype effect and allowed us to assess Ptdlns 4-kinase
activity. If Ptdlns 4-kinase controls MMP secretion, then it provides a potential
intervention in treating congestive heart failure and other cardiovascular diseases.
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Materials and Methods
Ptdlns 4-kinase dominant negative alleles
The dominant negative alleles were created using a S. cerevisiae Ptdlns 4-kinase
called Pikl. The Pikl gene encodes for a hydrophilic protein (1066 amino acids) that is a
homo log of the mammalian Ptdlns 4-kinase. The other types of Ptdlns 4-kinase in yeast
are Stt4p, which has an unknown role in secretion, and LSB6, which does not seem to
have an essential role 14 • The catalytic domain of Pikl was subjected to PCR mutagenesis
to generate a point mutation and cause it to be inactive. Mutated gene sequence was
amplified using PCR and was inserted into a bicistronic mammalian expression vector
(pIRES vector, Clontech) containing green fluorescent protein (GFP). A simultaneous
expression of both the gene of interest and GFP is achieved and this allowed us to rapidly
select transfected cells. The recombinant plasmids were digested and run using agarose
gel electrophoresis to verify that the gene encoding Ptdlns 4-kinase was integrated with
the vector. Plasmids were amplified using E. coli DH5a and were purified by
precipitation with polyethylene glycol.

Cardiac Cell Culture
One to two days old mice were anesthetized on ice and killed by decapitation.
Hearts were isolated and the ventricular tissues were digested in 0.25% trypsin in Hanks
buffered saline solution (HBSS) for 10-15 minutes and were incubated with shaking at 37
0

c.

For every 5 minutes, contents were forcefully shaken to assist further breakdown of

the remaining fragments into singly dispersed cells. Contents were poured through a
sterile funnel-fitted tube with gauze that was initially pre-wetted with 5 mL of serum
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supplemented medium (90% Dulbecco's Modified Eagle's Medium (DMEM), 10% Fetal
Bovine Serum). Cells were centrifuged at 1,000 rpm for 10 minutes and were
resuspended using serum supplemented medium. After 60 minutes at 37 °c,the nonadherent myocytes were aspirated and a new medium containing 500 ug/ml penicillin and
streptomyocin was added to the flask. The adherent cells were predominately fibroblasts
and were cultured at 37 °c in a CO 2 incubator until confluency (5-7 days) and passaged
using standard trypsin-EDT A release.

Transfection
One day before transfection, 2-8 x 105 cells were plated in a 6-well plate
containing growth medium without antibiotics. When cells are 80-90% confluent, they
were transfected using Lipofectamine from Invitrogen. For each transfection sample,
DNA and Lipofectamine were mixed and incubated for 20 minutes at room temperature
to create DNA-Lipofectamine complexes. These complexes were added to each well
containing cells and medium. Cells were incubated at 37 °c in a CO 2 incubator for 2448 hours. After transfection, GFP expression was monitored using Bio Rad 1024 laser
scanning confocal microscope.

In-gel Zymography
Cells were starved with serum-free media for 4-6 hours before collecting the
media for secreted MMPs. Cells were then collected by scraping and were lysed using a
vortex to determine retained MMPs in the cells. Equal volume samples were
concentrated in Microcon Centrifugal Filter Devices, YM-10 (Millipore Corporation,
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Bedford, MA 01730) and sodium dodecyl sulfate (SDS) sample buffer was added. In-gel
zymography was used to detect MMP activities and measure MMP levels. Zymogram
gels were prepared with 12% resolving or separating gel [Gelatin Type A, H20, 30%
acrylamide mix, 1.5 M Tris (pH 8.8), 10% SDS, 10% ammonium persulfate, TEMED]
and 5% stacking gel [H20, 30% acrylamide mix, 1.0 M Tris (pH 6.8), 10% SDS, 10%
ammonium persulfate, TEMED]. Samples were activated using l0mM of 4-aminophenyl
mercuric acetate (APMA) in 0.1 M NaOH for 2 hours in an incubator at 37

°c. Samples

were loaded and run at 120 mV (small gels) in Ix SDS Running Buffer. Gels were
removed from glass plates and soaked for 45 minutes in 2.5% Triton X-100 on a shaker.
Gels were incubated in digesting solution [IM Tris-HCl (pH 8), 1 M CaC'2, 1mM ZnC'2,
H20] for 24 hours at 37 °c. After incubation, gels were stained with Coomassie Blue for
about 15-30 minutes and destained with destaining solution [40% methanol, IO % acetic
acid, H 20] until the bands of lysis became clear.

8

Results
GFP expression by cardiac fibroblast cells was observed using a confocal
microscope. Transfection efficiency using Lipofectamine varied from 30-50% on all the
samples (Figure 1).

Control

Overexpressed
WT Kinase

Overexpressed
PM kinase

Figure 1. GFP expression in cardiac fibroblast cells. Fibroblast cells were transfected
with either an empty vector (left), a vector containing an overexpressed wt (middle), or a
vector containing an overexpressed pm (right).

MMP activities were observed using an in-gel zymography. Media samples were
collected after starving the cells with serum-free media to determine levels of secreted
MMPs. Additionally, the cells were collected to assess levels of retained MMPs inside
the cells. Control media and control cell lysate samples showed a slight MMP activity at
~ 55 kDa, while both media samples of overexpressed wt and overexpressed pm had no
MMP activity. In contrast, cell lysates of overexpressed wt and overexpressed pm
demonstrated MMP activities at ~55 kDa. Additional MMP activities were detected on
all cell lysate samples at ~22 kDa (Figure 2). A reasonable interpretation of these results
is that an MMP activity at ~55 kDa represents MMP13 and MMP activity at ~22 kDa
represents MMP 12. MMP 13 is a member of the collagenase family and is capable of
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degrading the fibrillar collagens of type I, II, III, and V. MMP12 is also known as
metalloelastase and is commonly found in macrophages
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Figure 2. In-gel zymography showing MMP activities. The arrows point to white
bands which indicate MMP activities while the dark bands represent other types of
protein. The white bands around 40 kDa are background noises caused by the gel
chamber. Media samples (Control, overexpressed wt, overexpressed pm) represent
secreted MMPs while cell lysate samples (Control, overexpressed wt, overexpressed pm)
represent MMPs retained in the cells.

Low levels ofMMPs were detected on the gel due to the addition of SOS sample
buffer containing ~-mercaptoethanol in media and cell lysate samples. The ~mercaptoethanol is a reducing agent that severely denatures the MMP conformation
which consequently prevents the MMP from refolding and becoming active after running
the gel. As a result, MMP activities were either reduced or prevented from occurring.

Conclusions
Most phosphoinositide kinases are considered to be heterodimers containing both
a catalytic and a regulatory protein subunits 12 • Previous reports have demonstrated that
overexpression of an inactive version of a catalytic protein subunit of a phosphoinositide
16
kinase created a dominant negative phenotype effect • In this situation, the inactive

catalytic protein subunits compete with wild type catalytic protein subunits.
Consequently, this will decrease the overall phosphoinositide kinase activity. In a similar
condition, overexpressing a wild type version of Ptdlns 4-kinase creates an analogous
effect with the dominant negative phenotype. It is unknown how this occurs, but it is
suggested that forced overexpression of Ptdlns 4-kinase in yeast and mammalian cells
creates an imbalance in the membrane trafficking system and causes the Golgi to
scatter 14 . Therefore, with the disruption of membrane trafficking, it is presumed that
MMP secretion is hindered.
Our results confirmed that Ptdlns 4-kinase regulates MMP secretion. As shown
in Figure 2, the absence of MMP13 secretion in media samples for both the
overexpressed wt and overexpressed pm indicated that MMP13 was not secreted outside
the cell. Instead, MMP13 for overexpressed wt and pm were kept inside the cell.
Therefore, we conclude that Ptdins 4-kinase activity is involved in Golgi-to-plasma
membrane vesicular transport. Further, we conclude that when Ptdins 4-kinase activity is
decreased or membrane trafficking is disrupted, MMPl 3 secretion decreases
correspondingly. To confirm if overexpression of Ptdins 4-kinase scatters the Golgi in
mammalian cells, Bodipy TR conjugated ceramide (Golgi stain) will be used to observe
any changes in the Golgi and to check for vesiculation. Contrary to the results of
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MMP13, MMP12 did not display a similar pattern; they were all seen in cell lysate
samples. Since MMPl 2 is associated with macrophages, perhaps high concentration of
macrophages existed in the cell culture.
In 1998, Tyagi discovered that high levels of specific MMPs (MMPl, MMP2,
2
MMP9) were found under heart failure conditions • This led us to predict that MMPI,

MMP2, and MMP9 have an essential role in remodeling the ECM of the heart and will be
highly secreted in mouse cardiac cells. However, our results indicate that MMP13 may
play an important role in cardiac cell function and ultimately in cardiovascular diseases.
A replication of this experiment will be completed to confirm our results. It is imperative
that we use SOS sample buffer without the ~-mercaptoethanol on all samples in order to
enhance the detection of MMP activities. Quantitative analysis of MMPs will also be
completed to determine the expression levels of MMPs.
This study will provide a greater understanding on the role of Ptdlns 4-kinase in
regulation of MMP secretion. By providing additional insights, this study will contribute
to the likely development of new drugs fur the treatment of cardiovascular diseases.

12

References:

I. Tyagi, S. C., Campbell, S. E., Reddy, H.K., Tjahja, E., and Voelker, D. J. (1996) Matrix
Metalloproteinase activity expression in infarcted, noninfarcted, and dilated cardiomyopathic human hearts.
Mo/ Cell Biochem I 55( I), 13-21.
2. Tyagi, S. (1998) Extracellular Matrix Dynamics in Heart Failure: A Prospect for Gene Therapy. J
Cell Biochem 68( 4), 403- I 0.
3. Hama, H., Schnieders, E. A., Thomer, J, Takemoto, J.Y., and DeWald, D.B. (1999) Direct
Involvement of Phosphatidylinositol 4-Phosphate in Secretion in the Yeast Saccharomyces cerevisiae. J
Biol Chem 274(48), 34294-300.
4. Walch-Solimena, C., and Novick, P. ( 1999) The yeast phosphatidylinositol-4-OH kinase pik I regulates
secretion at the Golgi. Nat Cell Biol 1(8), 523-5.
5. Audhya, A., Foti, M., and Emr, S. D. (2000) Distinct roles for the yeast phophatidylinositol 4-kinases,
stt4p and pik Ip, in secretion, cell growth, and organelle membrane dynamics. Mo/ Biol Cell 11(8), 267389.
6. Godi, A., Pertile, P., Meyers, R., Marra, P., Di Tullio, G., Lurisci, C., Luini, A., Corda, D., and De
Matteis, M. A. ( 1999) ARF mediates recruitment of Ptdlns-4-OH kinase-beta and stimulates synthesis of
Ptdlns (4,5) P2 on the Golgi complex. Nat Cell Biol 1(5), 280-7.
7. Lee, E. (2004). Regulation of Cardiac Fibroblast Metalloproteinase Secretion. American Heart
Association Undergraduate Summer Research Conference. Utah State University.
8. Thomas, T., Haase, N., Rosamond, W., Howard, V. A., Rumsfeld, J., Manolio, T., Zheng, Z., Flegal, K.,
O'Donnell, C. 0., Kittner, S., Goff, D. C., Hong, Y. (2006) Heart Disease and Stroke Statistics: 2006
Update. Circulation 113, e85-e 151.
9. Weber, K. T., Sun, Y., Tyagi, S. C., and Cleutjens, J.P. (1994) Collagen network ofthe myocardium:
function, structural remodeling and regulatory mechanisms. J Mo/ Cell Cardio 26(3), 279-92.
I 0. Gehnnann, T and Heilmeyer, L. M. G. ( 1998) Phosphatidylinositol 4-kinases. Eur J Biochem 253,
357-370.
11. Wong, K., Meyers dd, R., and Cantley, L.C. ( 1997) Subcellular locations of phosphatidylinositol 4kinase isoforms. J Biol Chem 272(20), 13236-41.
12. Martin, T. F. J. (1998) Phosphoinositide lipids as signaling molecules: Common themes for signal
transduction, cytoskeletal regulation, and membrane trafficking. Annu Rev Cell Dev Biol 14, 231-264.
I 3. Odorizzi, G., Babst, M., and Emr, S. D. (2000) Phosphoinositide signaling and the regulation of
membrane trafficking in yeast. Trends Biochem Sci 25(5), 229-35.
14. Wang, Y. J., Wang, J., Sun, H. Q., Martinez, M., Sun, Y. X., Macia, E., Kirchhausen, T., Albanesi, J.
P., Roth, M. G., and Yin, H. L. (2003). Phosphatidylinositol 4-phosphate regulates targeting of clathrin
adaptor AP- I complexes to the Golgi. Ce/1114, 299-310.
15. Westennarck, J., and Kahari, V. (1999). Regulation of matrix metalloproteinase expression in tumor
invasion. FASEB 13, 781-792.
16. Stack, J. H., Dewald, D.B., Takegawa, K., and Emr, S. D. (1995) Vesicle-mediated protein transport:
regulatory interactions between the Vps 15 protein kinase and the Vps34 Ptdlns 3-kinase essential for
protein sorting to the vacuole in yeast. J Cell Biol 129(2), 321-34.

13

